<Disease><Name>CORTISONE REDUCTASE DEFICIENCY 2; CORTRD2</Name><Synonym>11-BETA-HYDROXYSTEROID DEHYDROGENASE, TYPE I; HSD11B1</Synonym><OMIM><Number>614662</Number><URL>http://omim.org/entry/614662</URL></OMIM><Orphanet><Number>168588</Number><URL>http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=EN&amp;Expert=168588</URL></Orphanet><Protein><Number>Corticosteroid 11-beta-dehydrogenase isozyme 1</Number><URL>https://www.uniprot.org/uniprot/P28845</URL></Protein><ExPASy><Number>1.1.1.146</Number><URL>http://enzyme.expasy.org/EC/1.1.1.146</URL></ExPASy><Gene>1q32.2</Gene><ICD>E25.8</ICD><Summary>rare;autosomal dominant;mutation in the HSD11B1 gene</Summary><Symptoms><symtomp><id>3852</id><symptom>acanthosis nigrans</symptom><category>SKIN</category></symtomp><symtomp><id>2384</id><symptom>adrenal hyperplasia</symptom><category>ENDOCRINE SYSTEM | GASTROINTESTINAL SYSTEM</category></symtomp><symtomp><id>3333</id><symptom>bone age, advanced</symptom><category>LABORATORY FINDINGS</category></symtomp><symtomp><id>2372</id><symptom>obesity</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2507</id><symptom>onset, childhood / childhood</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>3236</id><symptom>polycystic ovaries</symptom><category>ENDOCRINE SYSTEM | GENITOURINARY TRACT</category></symtomp><symtomp><id>3795</id><symptom>premature pubarche</symptom><category>ENDOCRINE SYSTEM</category></symtomp><symtomp><id>3991</id><symptom>puberty, precocious</symptom><category>ENDOCRINE SYSTEM</category></symtomp><symtomp><id>2318</id><symptom>virilisation</symptom><category>GENERAL TOPICS</category></symtomp></Symptoms><Metabolites><metabolite><id>473</id><name>Adrenocorticotropic hormone (ACTH)</name><specimen>plasma</specimen><value>increased</value><min>10.00</min><max>20.00</max><unit>pg/ml</unit><age>child</age><method /><comment /></metabolite><metabolite><id>1195</id><name>Adrenocorticotropic hormone (ACTH)</name><specimen>plasma</specimen><value>increased</value><min>4.40</min><max>22.20</max><unit>pmol/l</unit><age>child</age><method /><comment /></metabolite></Metabolites><Literatures><literature><id>4746</id><title>[Importance of the 11&#946;-hydroxysteroid dehydrogenase enzyme in clinical disorders]</title><author>Feldman K,</author><journal>Orv Hetil</journal><year>2013</year><book /><volume>154</volume><number>8</number><pages>283-293</pages><co_aut>et al.</co_aut></literature><literature><id>4747</id><title>11&#946;-Hydroxysteroid dehydrogenase type 1: relevance of its modulation in the pathophysiology of obesity, the metabolic syndrome</title><author>Pereira CD,</author><journal>Diabetes Obes Metab</journal><year>2012</year><book /><volume>14</volume><number>10</number><pages>869-881</pages><co_aut>et al.</co_aut></literature><literature><id>4743</id><title>Cortisone-reductase deficiency associated with heterozygous mutations in 11beta-hydroxysteroid dehydrogenase type 1</title><author>Lawson AJ,</author><journal>Proc Natl Acad Sci U S A</journal><year>2011</year><book /><volume>108</volume><number>10</number><pages>4111-4116</pages><co_aut>et al.</co_aut></literature><literature><id>4748</id><title>11beta-hydroxysteroid dehydrogenase type 1 and obesity</title><author>Morton NM,</author><journal>Front Horm Res</journal><year>2008</year><book /><volume>36</volume><number>0</number><pages>146-164</pages><co_aut>Seckl JR</co_aut></literature><literature><id>4744</id><title>[11beta-hydroxysteroide dehydrogenases. Recent advances]</title><author>Vantyghem MC,</author><journal>Ann Endocrinol (Paris). 2007 Oct;68(5):349-56.</journal><year>2007</year><book /><volume>68</volume><number>5</number><pages>349-356</pages><co_aut>et al.</co_aut></literature><literature><id>4745</id><title>11beta-hydroxysteroid dehydrogenase type 1: a tissue-specific regulator of glucocorticoid response</title><author>Tomlinson JW,</author><journal>Endocr Rev</journal><year>2004</year><book /><volume>25</volume><number>5</number><pages>831-66</pages><co_aut>et al.</co_aut></literature></Literatures></Disease>